Cargando…
Genetic and Epigenetic Markers of Lithium Response
The mood stabilizer lithium represents a cornerstone in the long term treatment of bipolar disorder (BD), although with substantial interindividual variability in clinical response. This variability appears to be modulated by genetics, which has been significantly investigated in the last two decade...
Autores principales: | Pisanu, Claudia, Meloni, Anna, Severino, Giovanni, Squassina, Alessio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8836013/ https://www.ncbi.nlm.nih.gov/pubmed/35163479 http://dx.doi.org/10.3390/ijms23031555 |
Ejemplares similares
-
Analysis on in vitro effect of lithium on telomere length in lymphoblastoid cell lines from bipolar disorder patients with different clinical response to long-term lithium treatment
por: Squassina, Alessio, et al.
Publicado: (2022) -
RNA Biomarkers in Bipolar Disorder and Response to Mood Stabilizers
por: Pisanu, Claudia, et al.
Publicado: (2023) -
Treatment-Resistant Schizophrenia: Insights From Genetic Studies and Machine Learning Approaches
por: Pisanu, Claudia, et al.
Publicado: (2019) -
Investigating the Role of Leukocyte Telomere Length in Treatment-Resistant Depression and in Response to Electroconvulsive Therapy
por: Pisanu, Claudia, et al.
Publicado: (2021) -
Mood Disorders, Accelerated Aging, and Inflammation: Is the Link Hidden in Telomeres?
por: Squassina, Alessio, et al.
Publicado: (2019)